Literature DB >> 24656978

The validity of circulating microRNAs in oncology: five years of challenges and contradictions.

J Jarry1, D Schadendorf2, C Greenwood3, A Spatz4, L C van Kempen5.   

Abstract

MicroRNAs (miRNAs) in circulation have received an increasing amount of interest as potential minimal invasive diagnostic tools in oncology. Several diagnostic, prognostic and predictive signatures have been proposed for a variety of cancers at different stages of disease, but these have not been subjected to a critical review regarding their validity: reproducible identification in comparable studies and/or with different platforms of miRNA detection. In this review, we will critically address the results of circulating miRNA research in oncology that have been published between January 2008 and June 2013 (5.5 years), and discuss pre-analytical challenges, technological pitfalls and limitations that may contribute to the non-reproducibility of circulating miRNA research.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Circulating microRNAs; Diagnostic tool; Meta-analysis; Oncology

Mesh：

Substances：

Year:  2014        PMID： 24656978      PMCID： PMC5528532          DOI： 10.1016/j.molonc.2014.02.009

Source DB:  PubMed          Journal:  Mol Oncol        ISSN： 1574-7891            Impact factor:   6.603


  109 in total

1.  miRNA expression profiling for identification of potential breast cancer biomarkers.

Authors:  Kjersti Tjensvoll; Kine N Svendsen; James M Reuben; Satu Oltedal; Bjørnar Gilje; Rune Smaaland; Oddmund Nordgård
Journal:  Biomarkers       Date:  2012-05-17       Impact factor: 2.658

2.  Limit of blank, limit of detection and limit of quantitation.

Authors:  David A Armbruster; Terry Pry
Journal:  Clin Biochem Rev       Date:  2008-08

3.  MiRNA-199a-3p: A potential circulating diagnostic biomarker for early gastric cancer.

Authors:  Chen Li; Jian Fang Li; Qu Cai; Qing Qing Qiu; Min Yan; Bing Ya Liu; Zheng Gang Zhu
Journal:  J Surg Oncol       Date:  2013-06-03       Impact factor: 3.454

4.  A flexible genome-wide bootstrap method that accounts for ranking and threshold-selection bias in GWAS interpretation and replication study design.

Authors:  Laura L Faye; Lei Sun; Apostolos Dimitromanolakis; Shelley B Bull
Journal:  Stat Med       Date:  2011-05-03       Impact factor: 2.373

5.  Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease.

Authors:  Luke A Selth; Scott Townley; Joanna L Gillis; Aleksandra M Ochnik; Krisna Murti; Robyn J Macfarlane; Kim N Chi; Villis R Marshall; Wayne D Tilley; Lisa M Butler
Journal:  Int J Cancer       Date:  2011-11-03       Impact factor: 7.396

6.  Decreased serum miR-181a is a potential new tool for breast cancer screening.

Authors:  Li-Juan Guo; Qing-Yun Zhang
Journal:  Int J Mol Med       Date:  2012-06-11       Impact factor: 4.101

7.  Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma.

Authors:  S Komatsu; D Ichikawa; H Takeshita; M Tsujiura; R Morimura; H Nagata; T Kosuga; D Iitaka; H Konishi; A Shiozaki; H Fujiwara; K Okamoto; E Otsuji
Journal:  Br J Cancer       Date:  2011-06-14       Impact factor: 7.640

8.  Plasma microRNAs as potential biomarkers for non-small-cell lung cancer.

Authors:  Jun Shen; Nevins W Todd; Howard Zhang; Lei Yu; Xing Lingxiao; Yuping Mei; Maria Guarnera; Jipei Liao; Amy Chou; Changwan Larry Lu; Zhengran Jiang; HongBin Fang; Ruth L Katz; Feng Jiang
Journal:  Lab Invest       Date:  2010-11-29       Impact factor: 5.662

9.  Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors.

Authors:  Carina Roth; Isabel Stückrath; Klaus Pantel; Jakob R Izbicki; Michael Tachezy; Heidi Schwarzenbach
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

10.  Identification and evaluation of plasma microRNAs for early detection of colorectal cancer.

Authors:  Xiaoya Luo; Christian Stock; Barbara Burwinkel; Hermann Brenner
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240
View more
  67 in total

Review 1.  Circulating glioma biomarkers.

Authors:  Johan M Kros; Dana M Mustafa; Lennard J M Dekker; Peter A E Sillevis Smitt; Theo M Luider; Ping-Pin Zheng
Journal:  Neuro Oncol       Date:  2014-09-24       Impact factor: 12.300

Review 2.  The validity of circulating microRNAs in oncology: five years of challenges and contradictions.

Authors:  J Jarry; D Schadendorf; C Greenwood; A Spatz; L C van Kempen
Journal:  Mol Oncol       Date:  2014-03-06       Impact factor: 6.603

Review 3.  Exosomes: from carcinogenesis and metastasis to diagnosis and treatment of gastric cancer.

Authors:  Houman Kahroba; Mohammad Saeid Hejazi; Nasser Samadi
Journal:  Cell Mol Life Sci       Date:  2019-02-08       Impact factor: 9.261

4.  Circulating MicroRNA Quantification Using DNA-binding Dye Chemistry and Droplet Digital PCR.

Authors:  Manuela Ferracin; Irene Salamon; Laura Lupini; Elena Miotto; Silvia Sabbioni; Massimo Negrini
Journal:  J Vis Exp       Date:  2016-06-26       Impact factor: 1.355

Review 5.  MicroRNAs as biomarkers for clinical studies.

Authors:  Igor P Pogribny
Journal:  Exp Biol Med (Maywood)       Date:  2017-09-15

6.  Serum microRNA-193b as a promising biomarker for prediction of chemoradiation sensitivity in esophageal squamous cell carcinoma patients.

Authors:  Chung Man Chan; Kenneth K Y Lai; Enders K O Ng; Mei Na Kiang; Tiffany W H Kwok; Hector K Wang; Kwok Wah Chan; Tsz Ting Law; Daniel K Tong; Kin Tak Chan; Nikki P Lee; Simon Law
Journal:  Oncol Lett       Date:  2017-12-27       Impact factor: 2.967

Review 7.  Emergence of Circulating MicroRNAs in Breast Cancer as Diagnostic and Therapeutic Efficacy Biomarkers.

Authors:  Vaishali Aggarwal; Kumari Priyanka; Hardeep Singh Tuli
Journal:  Mol Diagn Ther       Date:  2020-04       Impact factor: 4.074

8.  Gastric adenocarcinoma microRNA profiles in fixed tissue and in plasma reveal cancer-associated and Epstein-Barr virus-related expression patterns.

Authors:  Amanda L Treece; Daniel L Duncan; Weihua Tang; Sandra Elmore; Douglas R Morgan; Ricardo L Dominguez; Olga Speck; Michael O Meyers; Margaret L Gulley
Journal:  Lab Invest       Date:  2016-03-07       Impact factor: 5.662

9.  Intra-individual variation of miRNA expression levels in human plasma samples.

Authors:  Jie Wu; Hui Cai; Yong-Bing Xiang; Charles E Matthews; Fei Ye; Wei Zheng; Qiuyin Cai; Xiao-Ou Shu
Journal:  Biomarkers       Date:  2018-01-30       Impact factor: 2.658

Review 10.  Liquid biopsy utility for the surveillance of cutaneous malignant melanoma patients.

Authors:  Sharon K Huang; Dave S B Hoon
Journal:  Mol Oncol       Date:  2015-12-17       Impact factor: 6.603
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.